The AST/ALT (De Ritis) ratio predicts clinical outcome in patients with pancreatic cancer treated with first-line nab-paclitaxel and gemcitabine:

Jakob Michael Riedl; Florian Posch; Gerald Prager; Wolfgang Eisterer; Leopold Oehler; Thamer Sliwa; Klaus Wilthoner; Andreas Petzer; Petra Pichler; Eva Hubmann; Thomas Winder; Sonja Burgstaller; Markus Korger; Johannes Andel; Richard Greil; Hans-Joerg Neumann; Martin Pecherstorfer; Kathrin Philipp-Abbrederis; Angela Djanani; Birgit Gruenberger; Friedrich Laengle; Ewald Wöll; Armin Gerger

doi:10.1177/1758835919900872

The AST/ALT (De Ritis) ratio predicts clinical outcome in patients with pancreatic cancer treated with first-line nab-paclitaxel and gemcitabine:

Jakob Michael Riedl, Florian Posch, Gerald Prager, Wolfgang Eisterer, Leopold Oehler, Thamer Sliwa, Klaus Wilthoner, Andreas Petzer, Petra Pichler, Eva Hubmann, Thomas Winder, Sonja Burgstaller, Markus Korger, Johannes Andel, Richard Greil (Co-author), Hans-Joerg Neumann, Martin Pecherstorfer, Kathrin Philipp-Abbrederis, Angela Djanani, Birgit GruenbergerFriedrich Laengle, Ewald Wöll, Armin Gerger

Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center

Research output: Contribution to journal › Original Article › peer-review

31 Citations (Web of Science)

Original language	English
Pages (from-to)	1758835919900872
Journal	THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
Volume	12
DOIs	https://doi.org/10.1177/1758835919900872
Publication status	Published - 2020

Keywords

PROGNOSTIC-FACTORS
SURVIVAL

Access to Document

10.1177/1758835919900872

Cite this

Riedl, J. M., Posch, F., Prager, G., Eisterer, W., Oehler, L., Sliwa, T., Wilthoner, K., Petzer, A., Pichler, P., Hubmann, E., Winder, T., Burgstaller, S., Korger, M., Andel, J., Greil, R., Neumann, H.-J., Pecherstorfer, M., Philipp-Abbrederis, K., Djanani, A., ... Gerger, A. (2020). The AST/ALT (De Ritis) ratio predicts clinical outcome in patients with pancreatic cancer treated with first-line nab-paclitaxel and gemcitabine: . THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 12, 1758835919900872. https://doi.org/10.1177/1758835919900872

@article{4c47e5f85e424fe1b4683929c98895b4,

title = "The AST/ALT (De Ritis) ratio predicts clinical outcome in patients with pancreatic cancer treated with first-line nab-paclitaxel and gemcitabine: ",

keywords = "PROGNOSTIC-FACTORS, SURVIVAL",

author = "Riedl, {Jakob Michael} and Florian Posch and Gerald Prager and Wolfgang Eisterer and Leopold Oehler and Thamer Sliwa and Klaus Wilthoner and Andreas Petzer and Petra Pichler and Eva Hubmann and Thomas Winder and Sonja Burgstaller and Markus Korger and Johannes Andel and Richard Greil and Hans-Joerg Neumann and Martin Pecherstorfer and Kathrin Philipp-Abbrederis and Angela Djanani and Birgit Gruenberger and Friedrich Laengle and Ewald W{\"o}ll and Armin Gerger",

note = "Greil: IIIrd Medical Department, Paracelsus Medical University Salzburg, Salzburg Cancer Research Institute, Cancer Cluster Salzburg, Salzburg, Austria",

year = "2020",

doi = "10.1177/1758835919900872",

language = "English",

volume = "12",

pages = "1758835919900872",

journal = "THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY",

issn = "1758-8340",

}

Riedl, JM, Posch, F, Prager, G, Eisterer, W, Oehler, L, Sliwa, T, Wilthoner, K, Petzer, A, Pichler, P, Hubmann, E, Winder, T, Burgstaller, S, Korger, M, Andel, J, Greil, R, Neumann, H-J, Pecherstorfer, M, Philipp-Abbrederis, K, Djanani, A, Gruenberger, B, Laengle, F, Wöll, E & Gerger, A 2020, 'The AST/ALT (De Ritis) ratio predicts clinical outcome in patients with pancreatic cancer treated with first-line nab-paclitaxel and gemcitabine: ', THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, vol. 12, pp. 1758835919900872. https://doi.org/10.1177/1758835919900872

TY - JOUR

T1 - The AST/ALT (De Ritis) ratio predicts clinical outcome in patients with pancreatic cancer treated with first-line nab-paclitaxel and gemcitabine:

AU - Riedl, Jakob Michael

AU - Posch, Florian

AU - Prager, Gerald

AU - Eisterer, Wolfgang

AU - Oehler, Leopold

AU - Sliwa, Thamer

AU - Wilthoner, Klaus

AU - Petzer, Andreas

AU - Pichler, Petra

AU - Hubmann, Eva

AU - Winder, Thomas

AU - Burgstaller, Sonja

AU - Korger, Markus

AU - Andel, Johannes

AU - Greil, Richard

AU - Neumann, Hans-Joerg

AU - Pecherstorfer, Martin

AU - Philipp-Abbrederis, Kathrin

AU - Djanani, Angela

AU - Gruenberger, Birgit

AU - Laengle, Friedrich

AU - Wöll, Ewald

AU - Gerger, Armin

N1 - Greil: IIIrd Medical Department, Paracelsus Medical University Salzburg, Salzburg Cancer Research Institute, Cancer Cluster Salzburg, Salzburg, Austria

PY - 2020

Y1 - 2020

KW - PROGNOSTIC-FACTORS

KW - SURVIVAL

U2 - 10.1177/1758835919900872

DO - 10.1177/1758835919900872

M3 - Original Article

C2 - 32313566

SN - 1758-8340

VL - 12

SP - 1758835919900872

JO - THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY

JF - THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY

ER -